Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5409872 | 0.73 | HSD17B10 (0.40) | HSD17B10 | |
| SCHEMBL5277391 | 0.71 | HSD11B1 (0.32) | HSD17B10 | |
| SCHEMBL11014352 | 0.70 | CYP19A1 (0.42) | HSD17B10 | |
| SCHEMBL10816509 | 0.70 | HSD17B10 (0.59) | HSD17B10 | |
| SCHEMBL4562939 | 0.70 | HSD17B10 (0.59) | HSD17B10 | |
| SCHEMBL9007717 | 0.69 | HSD17B10 (0.35) | HSD17B10 | |
| SCHEMBL15914848 | 0.68 | HSD17B10 (0.40) | HSD17B10 | |
| SCHEMBL2992831 | 0.68 | HSD17B10 (0.36) | HSD17B10 | |
| SCHEMBL11348086 | 0.67 | ALDH1A1 (0.35) | HSD17B10 | |
| SCHEMBL15915674 | 0.67 | HSD17B10 (0.35) | HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9243098-B2 | Compound, polymer, cross-linked compound of polymer, and optical element including cross-linked compound | CANON KABUSHIKI KAISHA (JP) | 2016-01-26 | — | — | US | disclosed |
| US-20140163175-A1 | NOVEL COMPOUND, POLYMER, CROSS-LINKED COMPOUND OF POLYMER, AND OPTICAL ELEMENT INCLUDING CROSS-LINKED COMPOUND | CANON KABUSHIKI KAISHA (JP) | 2014-06-12 | — | — | US | disclosed |
| WO-2013018817-A1 | NOVEL COMPOUND, POLYMER, CROSS-LINKED COMPOUND OF POLYMER, AND OPTICAL ELEMENT INCLUDING CROSS-LINKED COMPOUND | CANON KABUSHIKI KAISHA (JP) | 2013-02-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140163175-A1 | NOVEL COMPOUND, POLYMER, CROSS-LINKED COMPOUND OF POLYMER, AND OPTICAL ELEMENT INCLUDING CROSS-LINKED COMPOUND | PCLAF, PCNA, SMC2 | HSD17B10 1969/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.